• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病的临床病理特征

Clinicopathological aspects of Parkinson's disease.

作者信息

Hughes A J

机构信息

Department of Neurology, Austin and Repatriation Medical Centre (Repatriation Campus), Heidelberg West, Vic., Australia.

出版信息

Eur Neurol. 1997;38 Suppl 2:13-20. doi: 10.1159/000113471.

DOI:10.1159/000113471
PMID:9387798
Abstract

Clinicopathological studies have shown that the accuracy of a clinical diagnosis of Parkinson's disease (PD) is less than 80%. More selected diagnostic criteria can increase the proportion of true PD cases identified to more than 90%. However, by using these criteria almost a third of pathologically confirmed cases may be rejected. Awareness of the high misdiagnosis rate and refinements in the clinical diagnostic criteria for other conditions that may present with parkinsonism seem to have led to an improvement in the accuracy of diagnosis to 84%. Cortical Lewy bodies, often in small numbers, are seen in almost all patients with PD. This has prompted intense efforts to clarify both the clinical and pathological criteria for diffuse Lewy body disease. The nomenclature of conditions with plentiful numbers of Lewy bodies in the neocortex and the relevance of associated pathology has become confusing and the subject of intense nosological debate. A recent consensus paper has suggested clinical and pathological diagnostic criteria for what has been termed 'dementia with Lewy bodies'. This new term awaits general acceptance while the proposed diagnostic criteria remain to be validated. The neuropathological substrate of dementia in PD continues to receive a lot of attention with suggestions that additive deficits from pathology in both cortical and subcortical structures probably explain most of the dementia seen in PD.

摘要

临床病理研究表明,帕金森病(PD)临床诊断的准确率低于80%。更严格的诊断标准可使确诊的真正PD病例比例增至90%以上。然而,采用这些标准时,几乎三分之一经病理证实的病例可能会被排除。对高误诊率的认识以及对可能表现为帕金森综合征的其他疾病临床诊断标准的完善,似乎已使诊断准确率提高到了84%。几乎所有PD患者都可见到数量通常较少的皮质路易小体。这促使人们努力去明确弥漫性路易体病的临床和病理标准。新皮质中存在大量路易小体的疾病命名以及相关病理学的关联性已变得令人困惑,成为了激烈的疾病分类学争论的主题。最近的一篇共识论文提出了针对所谓“路易体痴呆”的临床和病理诊断标准。在这些拟议的诊断标准得到验证之前,这个新术语尚有待普遍接受。PD中痴呆的神经病理学基础一直备受关注,有观点认为,皮质和皮质下结构的病理学累加缺陷可能解释了PD中所见的大部分痴呆。

相似文献

1
Clinicopathological aspects of Parkinson's disease.帕金森病的临床病理特征
Eur Neurol. 1997;38 Suppl 2:13-20. doi: 10.1159/000113471.
2
Lewy body disease and dementia. A review.路易体病与痴呆。综述。
Arch Intern Med. 1996 Mar 11;156(5):487-93.
3
Lewy body cortical involvement may not always predict dementia in Parkinson's disease.路易体在皮质的累及并不总是能预测帕金森病患者是否会出现痴呆。
J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):852-6. doi: 10.1136/jnnp.74.7.852.
4
Simplified neuropathological diagnosis of dementia with Lewy bodies.路易体痴呆的简化神经病理学诊断
Neuropathol Appl Neurobiol. 1998 Jun;24(3):195-201. doi: 10.1046/j.1365-2990.1998.00115.x.
5
Dementia with Lewy bodies.路易体痴呆
Baillieres Clin Neurol. 1997 Apr;6(1):147-66.
6
In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease.路易体痴呆早期活体小胶质细胞激活与帕金森病的比较。
Parkinsonism Relat Disord. 2013 Jan;19(1):47-52. doi: 10.1016/j.parkreldis.2012.07.002. Epub 2012 Jul 26.
7
Fulminant Lewy body disease.暴发性路易体病
Mov Disord. 2006 Oct;21(10):1748-51. doi: 10.1002/mds.21034.
8
A review of Lewy body disease, an emerging concept of cortical dementia.
J Neuropsychiatry Clin Neurosci. 1998 Summer;10(3):267-79. doi: 10.1176/jnp.10.3.267.
9
Dementia in Parkinson's disease: cause and treatment.帕金森病中的痴呆:病因与治疗
Curr Opin Neurol. 2004 Aug;17(4):399-404. doi: 10.1097/01.wco.0000137529.30750.ab.
10
Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.帕金森病、帕金森病痴呆和路易体痴呆的谱系
Neurol Clin. 2000 Nov;18(4):865-902. doi: 10.1016/s0733-8619(05)70230-9.

引用本文的文献

1
ELECTRONIC PLATFORM MEASURES OF BALANCE IMPAIRMENT IN PARKINSONIANS AND FIRST DEGREE RELATIVES.帕金森病患者及其一级亲属平衡功能障碍的电子平台测量
Int J Pure Appl Math. 2004;13(2):259-272.
2
Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging.帕金森病痴呆患者纹状体淀粉样斑块的存在预示合并阿尔茨海默病:对淀粉样成像的意义
J Parkinsons Dis. 2012 Jan 1;2(1):57-65. doi: 10.3233/JPD-2012-11073.
3
Evidence for more than one Parkinson's disease-associated variant within the HLA region.
该区域内存在多种与帕金森病相关的 HLA 变异体证据。
PLoS One. 2011;6(11):e27109. doi: 10.1371/journal.pone.0027109. Epub 2011 Nov 9.
4
A cross-study transcriptional analysis of Parkinson's disease.一项关于帕金森病的跨研究转录分析。
PLoS One. 2009;4(3):e4955. doi: 10.1371/journal.pone.0004955. Epub 2009 Mar 23.
5
Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease.在1-甲基-4-苯基-1,2,3,6-四氢吡啶诱导的帕金森病中,半胱天冬酶-9的激活导致下游半胱天冬酶-8的激活和Bid的裂解。
J Neurosci. 2001 Dec 15;21(24):9519-28. doi: 10.1523/JNEUROSCI.21-24-09519.2001.